+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Animal Sedative Market Size, Share & Trends Analysis Report By Route of Administration, By Animal Type, By Drug Class, By End Use (Hospitals and Specialty Centers), By Application (Surgical, Diagnostic, and Others), By Regional Outlook and Forecast, 2024 - 2031

  • PDF Icon

    Report

  • 323 Pages
  • July 2024
  • Region: Global
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5988785
The Global Animal Sedative Market size is expected to reach $489.1 million by 2031, rising at a market growth of 5.5% CAGR during the forecast period.

The Asia Pacific region is seeing an expansion of veterinary clinics, hospitals, and specialty centers offering comprehensive healthcare services for animals. This expansion includes advanced diagnostic capabilities and surgical interventions, where sedatives are essential for safe and effective treatment. Consequently, the Asia Pacific region would acquire nearly 27% of the total market share by 2031.



There is a growing recognition of animals as sentient beings deserving of humane treatment. This perspective is driving demand for sedatives that minimize stress, anxiety, and pain during veterinary procedures, ensuring animals are treated with compassion and care. Similarly, pet owners and the general public are increasingly educated about animal welfare issues and expect high standards of care for their pets. Hence, a rising focus on animal welfare propels the market's growth.

Additionally, the growing specialization within veterinary medicine, such as dermatology, dentistry, oncology, and orthopedics, has led to a higher demand for sedatives tailored to specific medical procedures. In addition, the establishment of specialty veterinary centers focused on specific areas of expertise, such as emergency care, critical care, and rehabilitation, drives the need for advanced sedation techniques. Thus, the expansion of veterinary services is driving the market's growth.

However, Sedative products often involve high procurement costs for veterinary practices. This includes the initial purchase of sedative formulations and ongoing expenses related to anesthesia equipment, monitoring devices, and disposables. In addition, veterinarians must weigh the cost-effectiveness of using sedatives against alternative methods of restraint or anesthesia. Thus, the high cost of sedative products is hindering market growth.

Moreover, restrictions on transportation and logistics disrupted the supply chain for pharmaceutical products, including these sedatives. In addition, veterinary clinics and hospitals shifted their focus to emergency and essential care services during the pandemic, prioritizing treatments that did not require sedation unless necessary. Thus, the COVID-19 pandemic had a negative impact on the market.

Driving and Restraining Factors

Drivers
  • Rising focus on animal welfare
  • Expansion of veterinary services
  • Increasing pet ownership globally
Restraints
  • High cost of sedative products
  • Limited availability of specialized equipment
Opportunities
  • Supportive care in chronic conditions
  • Increasing veterinary telemedicine and home care
Challenges
  • Adverse effects and safety concerns
  • Limited pharmacological options

Route of Administration Outlook

By route of administration, the market is divided into parenteral and oral. The oral segment procured 40% revenue share in the market in 2023. Oral administration does not require needles or syringes. This can be less stressful for animals and more convenient for owners and veterinary staff.

Application Outlook

Based on application, the market is divided into surgical, diagnostic, and others. In 2023, the diagnostic segment procured 36% revenue share in the market. Sedatives often calm animals and reduce movement during diagnostic imaging procedures such as X-rays, ultrasounds, CT scans, and MRIs.



Animal Type Outlook

Based on animal type, the market is divided into dogs, cats, horses, and others. The cats segment attained 25% revenue share in the market in 2023. Regular veterinary visits, including vaccinations, check-ups, and minor procedures, often necessitate using sedatives for cats.

Drug Class Outlook

On the basis of drug class, the market is segmented into phenothiazines, benzodiazepines, alpha-2 adrenergic receptor agonists, butyrophenones, and others. In 2023, the benzodiazepines segment attained 24% revenue share in the market. Benzodiazepines, such as diazepam and midazolam, are highly effective in reducing stress and anxiety in animals. This makes them invaluable for calming animals during veterinary visits, grooming, transportation, and other potentially stressful situations.

End Use Outlook

Based on end use, the market is categorized into hospitals and specialty centers. The specialty centers segment witnessed 48% growth rate in the market in 2023. Specialty centers provide specialized veterinary care in specific areas such as oncology, neurology, cardiology, dermatology, and emergency critical care.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region witnessed 38% revenue share in the market in 2023. North America has one of the highest rates of pet ownership globally, with a large population of dogs, cats, and other companion animals.

List of Key Companies Profiled

  • Koninklijke Philips N.V.
  • Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Visiopharm A/S
  • Paige AI, Inc.
  • PathAI, Inc.
  • Aiforia Technologies Plc
  • Indica Labs, Inc.
  • Optrascan, Inc. (Optra Ventures, LLC)
  • MindPeak GmbH

Market Report Segmentation

By Route of Administration
  • Parenteral
  • Oral
By Animal Type
  • Dogs
  • Cats
  • Horses
  • Others
By Drug Class
  • Alpha-2 Adrenergic Receptor Agonists
  • Phenothiazines
  • Benzodiazepines
  • Butyrophenones
  • Others
By End Use
  • Hospitals
  • Specialty Centers
By Application
  • Surgical
  • Diagnostic
  • Others
By Geography
  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Animal Sedative Market, by Route of Administration
1.4.2 Global Animal Sedative Market, by Animal Ty pe
1.4.3 Global Animal Sedative Market, by Drug Class
1.4.4 Global Animal Sedative Market, by End Use
1.4.5 Global Animal Sedative Market, by Application
1.4.6 Global Animal Sedative Market, by Geography
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Global Animal Sedative Market by Route of Administration
4.1 Global Parenteral Market by Region
4.2 Global Oral Market by Region
Chapter 5. Global Animal Sedative Market by Animal Type
5.1 Global Dogs Market by Region
5.2 Global Cats Market by Region
5.3 Global Horses Market by Region
5.4 Global Others Market by Region
Chapter 6. Global Animal Sedative Market by Drug Class
6.1 Global Alpha-2 Adrenergic Receptor Agonists Market by Region
6.2 Global Phenothiazines Market by Region
6.3 Global Benzodiazepines Market by Region
6.4 Global Butyrophenones Market by Region
6.5 Global Others Market by Region
Chapter 7. Global Animal Sedative Market by End Use
7.1 Global Hospitals Market by Region
7.2 Global Specialty Centers Market by Region
Chapter 8. Global Animal Sedative Market by Application
8.1 Global Surgical Market by Region
8.2 Global Diagnostic Market by Region
8.3 Global Others Market by Region
Chapter 9. Global Animal Sedative Market by Region
9.1 North America Animal Sedative Market
9.1.1 North America Animal Sedative Market by Route of Administration
9.1.1.1 North America Parenteral Market by Region
9.1.1.2 North America Oral Market by Region
9.1.2 North America Animal Sedative Market by Animal Type
9.1.2.1 North America Dogs Market by Country
9.1.2.2 North America Cats Market by Country
9.1.2.3 North America Horses Market by Country
9.1.2.4 North America Others Market by Country
9.1.3 North America Animal Sedative Market by Drug Class
9.1.3.1 North America Alpha-2 Adrenergic Receptor Agonists Market by Country
9.1.3.2 North America Phenothiazines Market by Country
9.1.3.3 North America Benzodiazepines Market by Country
9.1.3.4 North America Butyrophenones Market by Country
9.1.3.5 North America Others Market by Country
9.1.4 North America Animal Sedative Market by End Use
9.1.4.1 North America Hospitals Market by Country
9.1.4.2 North America Specialty Centers Market by Country
9.1.5 North America Animal Sedative Market by Application
9.1.5.1 North America Surgical Market by Country
9.1.5.2 North America Diagnostic Market by Country
9.1.5.3 North America Others Market by Country
9.1.6 North America Animal Sedative Market by Country
9.1.6.1 US Animal Sedative Market
9.1.6.1.1 US Animal Sedative Market by Route of Administration
9.1.6.1.2 US Animal Sedative Market by Animal Type
9.1.6.1.3 US Animal Sedative Market by Drug Class
9.1.6.1.4 US Animal Sedative Market by End Use
9.1.6.1.5 US Animal Sedative Market by Application
9.1.6.2 Canada Animal Sedative Market
9.1.6.2.1 Canada Animal Sedative Market by Route of Administration
9.1.6.2.2 Canada Animal Sedative Market by Animal Type
9.1.6.2.3 Canada Animal Sedative Market by Drug Class
9.1.6.2.4 Canada Animal Sedative Market by End Use
9.1.6.2.5 Canada Animal Sedative Market by Application
9.1.6.3 Mexico Animal Sedative Market
9.1.6.3.1 Mexico Animal Sedative Market by Route of Administration
9.1.6.3.2 Mexico Animal Sedative Market by Animal Type
9.1.6.3.3 Mexico Animal Sedative Market by Drug Class
9.1.6.3.4 Mexico Animal Sedative Market by End Use
9.1.6.3.5 Mexico Animal Sedative Market by Application
9.1.6.4 Rest of North America Animal Sedative Market
9.1.6.4.1 Rest of North America Animal Sedative Market by Route of Administration
9.1.6.4.2 Rest of North America Animal Sedative Market by Animal Type
9.1.6.4.3 Rest of North America Animal Sedative Market by Drug Class
9.1.6.4.4 Rest of North America Animal Sedative Market by End Use
9.1.6.4.5 Rest of North America Animal Sedative Market by Application
9.2 Europe Animal Sedative Market
9.2.1 Europe Animal Sedative Market by Route of Administration
9.2.1.1 Europe Parenteral Market by Country
9.2.1.2 Europe Oral Market by Country
9.2.2 Europe Animal Sedative Market by Animal Type
9.2.2.1 Europe Dogs Market by Country
9.2.2.2 Europe Cats Market by Country
9.2.2.3 Europe Horses Market by Country
9.2.2.4 Europe Others Market by Country
9.2.3 Europe Animal Sedative Market by Drug Class
9.2.3.1 Europe Alpha-2 Adrenergic Receptor Agonists Market by Country
9.2.3.2 Europe Phenothiazines Market by Country
9.2.3.3 Europe Benzodiazepines Market by Country
9.2.3.4 Europe Butyrophenones Market by Country
9.2.3.5 Europe Others Market by Country
9.2.4 Europe Animal Sedative Market by End Use
9.2.4.1 Europe Hospitals Market by Country
9.2.4.2 Europe Specialty Centers Market by Country
9.2.5 Europe Animal Sedative Market by Application
9.2.5.1 Europe Surgical Market by Country
9.2.5.2 Europe Diagnostic Market by Country
9.2.5.3 Europe Others Market by Country
9.2.6 Europe Animal Sedative Market by Country
9.2.6.1 Germany Animal Sedative Market
9.2.6.1.1 Germany Animal Sedative Market by Route of Administration
9.2.6.1.2 Germany Animal Sedative Market by Animal Type
9.2.6.1.3 Germany Animal Sedative Market by Drug Class
9.2.6.1.4 Germany Animal Sedative Market by End Use
9.2.6.1.5 Germany Animal Sedative Market by Application
9.2.6.2 UK Animal Sedative Market
9.2.6.2.1 UK Animal Sedative Market by Route of Administration
9.2.6.2.2 UK Animal Sedative Market by Animal Type
9.2.6.2.3 UK Animal Sedative Market by Drug Class
9.2.6.2.4 UK Animal Sedative Market by End Use
9.2.6.2.5 UK Animal Sedative Market by Application
9.2.6.3 France Animal Sedative Market
9.2.6.3.1 France Animal Sedative Market by Route of Administration
9.2.6.3.2 France Animal Sedative Market by Animal Type
9.2.6.3.3 France Animal Sedative Market by Drug Class
9.2.6.3.4 France Animal Sedative Market by End Use
9.2.6.3.5 France Animal Sedative Market by Application
9.2.6.4 Russia Animal Sedative Market
9.2.6.4.1 Russia Animal Sedative Market by Route of Administration
9.2.6.4.2 Russia Animal Sedative Market by Animal Type
9.2.6.4.3 Russia Animal Sedative Market by Drug Class
9.2.6.4.4 Russia Animal Sedative Market by End Use
9.2.6.4.5 Russia Animal Sedative Market by Application
9.2.6.5 Spain Animal Sedative Market
9.2.6.5.1 Spain Animal Sedative Market by Route of Administration
9.2.6.5.2 Spain Animal Sedative Market by Animal Type
9.2.6.5.3 Spain Animal Sedative Market by Drug Class
9.2.6.5.4 Spain Animal Sedative Market by End Use
9.2.6.5.5 Spain Animal Sedative Market by Application
9.2.6.6 Italy Animal Sedative Market
9.2.6.6.1 Italy Animal Sedative Market by Route of Administration
9.2.6.6.2 Italy Animal Sedative Market by Animal Type
9.2.6.6.3 Italy Animal Sedative Market by Drug Class
9.2.6.6.4 Italy Animal Sedative Market by End Use
9.2.6.6.5 Italy Animal Sedative Market by Application
9.2.6.7 Rest of Europe Animal Sedative Market
9.2.6.7.1 Rest of Europe Animal Sedative Market by Route of Administration
9.2.6.7.2 Rest of Europe Animal Sedative Market by Animal Type
9.2.6.7.3 Rest of Europe Animal Sedative Market by Drug Class
9.2.6.7.4 Rest of Europe Animal Sedative Market by End Use
9.2.6.7.5 Rest of Europe Animal Sedative Market by Application
9.3 Asia Pacific Animal Sedative Market
9.3.1 Asia Pacific Animal Sedative Market by Route of Administration
9.3.1.1 Asia Pacific Parenteral Market by Country
9.3.1.2 Asia Pacific Oral Market by Country
9.3.2 Asia Pacific Animal Sedative Market by Animal Type
9.3.2.1 Asia Pacific Dogs Market by Country
9.3.2.2 Asia Pacific Cats Market by Country
9.3.2.3 Asia Pacific Horses Market by Country
9.3.2.4 Asia Pacific Others Market by Country
9.3.3 Asia Pacific Animal Sedative Market by Drug Class
9.3.3.1 Asia Pacific Alpha-2 Adrenergic Receptor Agonists Market by Country
9.3.3.2 Asia Pacific Phenothiazines Market by Country
9.3.3.3 Asia Pacific Benzodiazepines Market by Country
9.3.3.4 Asia Pacific Butyrophenones Market by Country
9.3.3.5 Asia Pacific Others Market by Country
9.3.4 Asia Pacific Animal Sedative Market by End Use
9.3.4.1 Asia Pacific Hospitals Market by Country
9.3.4.2 Asia Pacific Specialty Centers Market by Country
9.3.5 Asia Pacific Animal Sedative Market by Application
9.3.5.1 Asia Pacific Surgical Market by Country
9.3.5.2 Asia Pacific Diagnostic Market by Country
9.3.5.3 Asia Pacific Others Market by Country
9.3.6 Asia Pacific Animal Sedative Market by Country
9.3.6.1 China Animal Sedative Market
9.3.6.1.1 China Animal Sedative Market by Route of Administration
9.3.6.1.2 China Animal Sedative Market by Animal Type
9.3.6.1.3 China Animal Sedative Market by Drug Class
9.3.6.1.4 China Animal Sedative Market by End Use
9.3.6.1.5 China Animal Sedative Market by Application
9.3.6.2 Japan Animal Sedative Market
9.3.6.2.1 Japan Animal Sedative Market by Route of Administration
9.3.6.2.2 Japan Animal Sedative Market by Animal Type
9.3.6.2.3 Japan Animal Sedative Market by Drug Class
9.3.6.2.4 Japan Animal Sedative Market by End Use
9.3.6.2.5 Japan Animal Sedative Market by Application
9.3.6.3 India Animal Sedative Market
9.3.6.3.1 India Animal Sedative Market by Route of Administration
9.3.6.3.2 India Animal Sedative Market by Animal Type
9.3.6.3.3 India Animal Sedative Market by Drug Class
9.3.6.3.4 India Animal Sedative Market by End Use
9.3.6.3.5 India Animal Sedative Market by Application
9.3.6.4 South Korea Animal Sedative Market
9.3.6.4.1 South Korea Animal Sedative Market by Route of Administration
9.3.6.4.2 South Korea Animal Sedative Market by Animal Type
9.3.6.4.3 South Korea Animal Sedative Market by Drug Class
9.3.6.4.4 South Korea Animal Sedative Market by End Use
9.3.6.4.5 South Korea Animal Sedative Market by Application
9.3.6.5 Singapore Animal Sedative Market
9.3.6.5.1 Singapore Animal Sedative Market by Route of Administration
9.3.6.5.2 Singapore Animal Sedative Market by Animal Type
9.3.6.5.3 Singapore Animal Sedative Market by Drug Class
9.3.6.5.4 Singapore Animal Sedative Market by End Use
9.3.6.5.5 Singapore Animal Sedative Market by Application
9.3.6.6 Malaysia Animal Sedative Market
9.3.6.6.1 Malaysia Animal Sedative Market by Route of Administration
9.3.6.6.2 Malaysia Animal Sedative Market by Animal Type
9.3.6.6.3 Malaysia Animal Sedative Market by Drug Class
9.3.6.6.4 Malaysia Animal Sedative Market by End Use
9.3.6.6.5 Malaysia Animal Sedative Market by Application
9.3.6.7 Rest of Asia Pacific Animal Sedative Market
9.3.6.7.1 Rest of Asia Pacific Animal Sedative Market by Route of Administration
9.3.6.7.2 Rest of Asia Pacific Animal Sedative Market by Animal Type
9.3.6.7.3 Rest of Asia Pacific Animal Sedative Market by Drug Class
9.3.6.7.4 Rest of Asia Pacific Animal Sedative Market by End Use
9.3.6.7.5 Rest of Asia Pacific Animal Sedative Market by Application
9.4 LAMEA Animal Sedative Market
9.4.1 LAMEA Animal Sedative Market by Route of Administration
9.4.1.1 LAMEA Parenteral Market by Country
9.4.1.2 LAMEA Oral Market by Country
9.4.2 LAMEA Animal Sedative Market by Animal Type
9.4.2.1 LAMEA Dogs Market by Country
9.4.2.2 LAMEA Cats Market by Country
9.4.2.3 LAMEA Horses Market by Country
9.4.2.4 LAMEA Others Market by Country
9.4.3 LAMEA Animal Sedative Market by Drug Class
9.4.3.1 LAMEA Alpha-2 Adrenergic Receptor Agonists Market by Country
9.4.3.2 LAMEA Phenothiazines Market by Country
9.4.3.3 LAMEA Benzodiazepines Market by Country
9.4.3.4 LAMEA Butyrophenones Market by Country
9.4.3.5 LAMEA Others Market by Country
9.4.4 LAMEA Animal Sedative Market by End Use
9.4.4.1 LAMEA Hospitals Market by Country
9.4.4.2 LAMEA Specialty Centers Market by Country
9.4.5 LAMEA Animal Sedative Market by Application
9.4.5.1 LAMEA Surgical Market by Country
9.4.5.2 LAMEA Diagnostic Market by Country
9.4.5.3 LAMEA Others Market by Country
9.4.6 LAMEA Animal Sedative Market by Country
9.4.6.1 Brazil Animal Sedative Market
9.4.6.1.1 Brazil Animal Sedative Market by Route of Administration
9.4.6.1.2 Brazil Animal Sedative Market by Animal Type
9.4.6.1.3 Brazil Animal Sedative Market by Drug Class
9.4.6.1.4 Brazil Animal Sedative Market by End Use
9.4.6.1.5 Brazil Animal Sedative Market by Application
9.4.6.2 Argentina Animal Sedative Market
9.4.6.2.1 Argentina Animal Sedative Market by Route of Administration
9.4.6.2.2 Argentina Animal Sedative Market by Animal Type
9.4.6.2.3 Argentina Animal Sedative Market by Drug Class
9.4.6.2.4 Argentina Animal Sedative Market by End Use
9.4.6.2.5 Argentina Animal Sedative Market by Application
9.4.6.3 UAE Animal Sedative Market
9.4.6.3.1 UAE Animal Sedative Market by Route of Administration
9.4.6.3.2 UAE Animal Sedative Market by Animal Type
9.4.6.3.3 UAE Animal Sedative Market by Drug Class
9.4.6.3.4 UAE Animal Sedative Market by End Use
9.4.6.3.5 UAE Animal Sedative Market by Application
9.4.6.4 Saudi Arabia Animal Sedative Market
9.4.6.4.1 Saudi Arabia Animal Sedative Market by Route of Administration
9.4.6.4.2 Saudi Arabia Animal Sedative Market by Animal Type
9.4.6.4.3 Saudi Arabia Animal Sedative Market by Drug Class
9.4.6.4.4 Saudi Arabia Animal Sedative Market by End Use
9.4.6.4.5 Saudi Arabia Animal Sedative Market by Application
9.4.6.5 South Africa Animal Sedative Market
9.4.6.5.1 South Africa Animal Sedative Market by Route of Administration
9.4.6.5.2 South Africa Animal Sedative Market by Animal Type
9.4.6.5.3 South Africa Animal Sedative Market by Drug Class
9.4.6.5.4 South Africa Animal Sedative Market by End Use
9.4.6.5.5 South Africa Animal Sedative Market by Application
9.4.6.6 Nigeria Animal Sedative Market
9.4.6.6.1 Nigeria Animal Sedative Market by Route of Administration
9.4.6.6.2 Nigeria Animal Sedative Market by Animal Type
9.4.6.6.3 Nigeria Animal Sedative Market by Drug Class
9.4.6.6.4 Nigeria Animal Sedative Market by End Use
9.4.6.6.5 Nigeria Animal Sedative Market by Application
9.4.6.7 Rest of LAMEA Animal Sedative Market
9.4.6.7.1 Rest of LAMEA Animal Sedative Market by Route of Administration
9.4.6.7.2 Rest of LAMEA Animal Sedative Market by Animal Type
9.4.6.7.3 Rest of LAMEA Animal Sedative Market by Drug Class
9.4.6.7.4 Rest of LAMEA Animal Sedative Market by End Use
9.4.6.7.5 Rest of LAMEA Animal Sedative Market by Application
Chapter 10. Company Profiles
10.1 Zoetis, Inc.
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Regional Analysis
10.1.4 Research & Development Expenses
10.1.5 Recent strategies and developments:
10.1.5.1 Product Launches and Product Expansions:
10.1.6 SWOT Analysis
10.2 Virbac
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Regional Analysis
10.2.4 Recent strategies and developments:
10.2.4.1 Product Launches and Product Expansions:
10.2.5 SWOT Analysis
10.3 Dechra Pharmaceuticals PLC
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental & Regional Analysis
10.3.4 Research & Development Expenses
10.3.5 Recent strategies and developments:
10.3.5.1 Product Launches and Product Expansions:
10.3.6 SWOT Analysis
10.4 Merck & Co., Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expenses
10.4.5 SWOT Analysis
10.5 Bimeda, Inc.
10.5.1 Company Overview
10.5.2 Recent strategies and developments:
10.5.2.1 Product Launches and Product Expansions:
10.5.3 SWOT Analysis
10.6 Ouro Fino Saude Animal Participacoes S.A.
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expenses
10.7 vetcare. fi.
10.7.1 Company Overview
10.8 Chanelle Pharma (Exponent)
10.8.1 Company Overview
10.9 Randlab Australia Pty Ltd.
10.9.1 Company Overview
10.10. Troy Laboratories Pty Ltd.
10.10.1 Company Overview
Chapter 11. Winning Imperatives of Animal Sedative Market

Companies Mentioned

  • Zoetis, Inc.
  • Virbac
  • Dechra Pharmaceuticals PLC
  • Merck & Co., Inc.
  • Bimeda, Inc.
  • Ouro Fino Saude Animal Participacoes S.A.
  • vetcare. fi.
  • Chanelle Pharma (Exponent)
  • Randlab Australia Pty Ltd.
  • Troy Laboratories Pty Ltd.

Methodology

Loading
LOADING...